Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Sivelestat Sodium in the Treatment of ARDS With SIRS
NCT04909697Phase 4Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sivelestat in acute respiratory distress syndrome (ARDS), sponsored by Sichuan Provincial People's Hospital. Started Apr 2022; status: completed.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04909697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909697.